By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Next-generation sequencing instrument firm LaserGen today announced it has closed its $5 million Series A financing round and signed on a life science consulting firm to assist with commercialization plans.

The $5 million round will be used to demonstrate accurate sequencing of the E. coli genome in the next few months, LaserGen said, and to develop the Baylor College of Medicine spinout's next-generation sequencing system.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.